 |
|
Elucidating molecular mechanisms of acquired resistance to BRAF inhibitors in melanoma using a microfluidic device and deep sequencing
Jiyeon Han, Yeonjoo Jung, Yukyung Jun, Sungsu Park, Sanghyuk Lee
Genomics Inform. 2021;19(1):e2 Published online 2021 Mar 15 DOI: https://doi.org/10.5808/gi.20074
|
|
Citations to this article as recorded by
 Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
S. Afsar, Rahamat Unissa Syed, Weam M. A. Khojali, Najat Masood, Mhdia Elhadi Osman, J. Siva Jyothi, Mohd. Abdul Hadi, Amna Abakar Suleiman Khalifa, Nayla Ahmed Mohammed Aboshouk, Hessa Ahmed Alsaikhan, Aljuri Saleh Alafnan, Bushra Abdullah Alrashidi
Naunyn-Schmiedeberg's Archives of Pharmacology.2024;[Epub] CrossRef Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment
Naji Kharouf, Thomas W. Flanagan, Sofie-Yasmin Hassan, Hosam Shalaby, Marla Khabaz, Sarah-Lilly Hassan, Mosaad Megahed, Youssef Haikel, Simeon Santourlidis, Mohamed Hassan
Cancers.2023; 15(12): 3147. CrossRef PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism
Ombretta Garbarino, Giulia Elda Valenti, Lorenzo Monteleone, Gabriella Pietra, Maria Cristina Mingari, Andrea Benzi, Santina Bruzzone, Silvia Ravera, Riccardo Leardi, Emanuele Farinini, Stefania Vernazza, Melania Grottoli, Barbara Marengo, Cinzia Domenico
Frontiers in Oncology.2023;[Epub] CrossRef Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Md Entaz Bahar, Hyun Joon Kim, Deok Ryong Kim
Signal Transduction and Targeted Therapy.2023;[Epub] CrossRef
|